Summary Nanosphere Inc (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company’s products comprise verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection tests, respiratory infection tests and cardiac tests. Its verigene system is used to identify and treat the bacteria and viruses. Nanosphere offers bloodstream infection tests such as gram-positive blood culture, gram-negative blood culture and yeast blood culture. The company’s cardiac tests include CYP2C19, warfarin metabolism and F5/F2/MTHFR. It provides tests for infections of the bloodstream, respiratory tract and gastrointestinal tract. Nanosphere is headquartered in Northbrook, Illinois, the US. Nanosphere Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their... Research Beam Model: Research Beam Product ID: 2114268 250 USD New
Nanosphere Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Nanosphere Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : September   2017
  • Pages : 22
  • Publisher : GlobalData
 
 
 
Summary

Nanosphere Inc (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company’s products comprise verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection tests, respiratory infection tests and cardiac tests. Its verigene system is used to identify and treat the bacteria and viruses. Nanosphere offers bloodstream infection tests such as gram-positive blood culture, gram-negative blood culture and yeast blood culture. The company’s cardiac tests include CYP2C19, warfarin metabolism and F5/F2/MTHFR. It provides tests for infections of the bloodstream, respiratory tract and gastrointestinal tract. Nanosphere is headquartered in Northbrook, Illinois, the US.

Nanosphere Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Nanosphere Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Nanosphere Inc, Medical Devices Deals, 2011 to YTD 2017 9
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Nanosphere Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Nanosphere Raises USD10 Million in Public Offering of Shares 11
Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock 13
Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock 14
Acquisition 15
Luminex Acquires Nanosphere in Tender Offer 15
Nanosphere Inc - Key Competitors 17
Nanosphere Inc - Key Employees 18
Nanosphere Inc - Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
May 16, 2016: Nanosphere Announces First Quarter Results 20
Feb 24, 2016: Nanosphere Announces Fourth Quarter and Full Year 2015 Results, 2016 Guidance and Next Generation Verigene Progress 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Nanosphere Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Nanosphere Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Nanosphere Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Nanosphere Inc, Medical Devices Deals, 2011 to YTD 2017 9
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Nanosphere Raises USD10 Million in Public Offering of Shares 11
Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock 13
Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock 14
Luminex Acquires Nanosphere in Tender Offer 15
Nanosphere Inc, Key Competitors 17
Nanosphere Inc, Key Employees 18
List of Figures
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Nanosphere Inc, Medical Devices Deals, 2011 to YTD 2017 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter